TY - JOUR AU - Siegel, R. AU - Ward, E. AU - Brawley, O. AU - Jemal, A. PY - 2011 DA - 2011// TI - Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20121 DO - 10.3322/caac.20121 ID - Siegel2011 ER - TY - JOUR AU - Davies, J. M. AU - Goldberg, R. M. PY - 2011 DA - 2011// TI - Treatment of metastatic colorectal cancer JO - Semin Oncol VL - 38 UR - https://doi.org/10.1053/j.seminoncol.2011.05.009 DO - 10.1053/j.seminoncol.2011.05.009 ID - Davies2011 ER - TY - JOUR AU - Tol, J. AU - Punt, C. J. PY - 2010 DA - 2010// TI - Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review JO - Clin Ther VL - 32 UR - https://doi.org/10.1016/j.clinthera.2010.03.012 DO - 10.1016/j.clinthera.2010.03.012 ID - Tol2010 ER - TY - JOUR AU - Bardelli, A. AU - Siena, S. PY - 2010 DA - 2010// TI - Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.24.6116 DO - 10.1200/JCO.2009.24.6116 ID - Bardelli2010 ER - TY - JOUR AU - Ottaiano, A. AU - Scala, S. AU - Iaffaioli, R. V. PY - 2010 DA - 2010// TI - Cetuximab-dependent ADCC in cancer: dream or reality? JO - Cancer Immunol Immunother VL - 59 UR - https://doi.org/10.1007/s00262-010-0884-3 DO - 10.1007/s00262-010-0884-3 ID - Ottaiano2010 ER - TY - JOUR AU - Correale, P. AU - Marra, M. AU - Remondo, C. PY - 2010 DA - 2010// TI - Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC) JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.03.005 DO - 10.1016/j.ejca.2010.03.005 ID - Correale2010 ER - TY - JOUR AU - Bier, H. AU - Hoffmann, T. AU - Haas, I. AU - van Lierop, A. PY - 1998 DA - 1998// TI - Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity 19 against squamous cell carcinoma lines of the head and neck JO - Cancer Immunol Immunother VL - 46 UR - https://doi.org/10.1007/s002620050475 DO - 10.1007/s002620050475 ID - Bier1998 ER - TY - JOUR AU - García-Foncillas, J. AU - Díaz-Rubio, E. PY - 2010 DA - 2010// TI - Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome JO - Clin Transl Oncol VL - 12 UR - https://doi.org/10.1007/s12094-010-0551-3 DO - 10.1007/s12094-010-0551-3 ID - García-Foncillas2010 ER - TY - JOUR AU - McKenzie, S. E. AU - Schreiber, A. D. PY - 1994 DA - 1994// TI - Biological advances and clinical applications of Fc receptors for IgG JO - Curr Opin Hematol VL - 1 ID - McKenzie1994 ER - TY - JOUR AU - Cartron, G. AU - Dacheux, L. AU - Salles, G. PY - 2002 DA - 2002// TI - Therapeutic activity of humanized anti-CD2 monoclonal antibody and polymorphism in IgG Fc receptor Fc RIIIa gene JO - Blood VL - 99 UR - https://doi.org/10.1182/blood.V99.3.754 DO - 10.1182/blood.V99.3.754 ID - Cartron2002 ER - TY - JOUR AU - Weng, W. K. AU - Levy, R. PY - 2003 DA - 2003// TI - Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.05.013 DO - 10.1200/JCO.2003.05.013 ID - Weng2003 ER - TY - JOUR AU - Carlotti, E. AU - Palumbo, G. A. AU - Oldani, E. PY - 2007 DA - 2007// TI - FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab JO - Haematologica VL - 92 UR - https://doi.org/10.3324/haematol.11288 DO - 10.3324/haematol.11288 ID - Carlotti2007 ER - TY - JOUR AU - Musolino, A. AU - Naldi, N. AU - Bortesi, B. PY - 2008 DA - 2008// TI - Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.8957 DO - 10.1200/JCO.2007.14.8957 ID - Musolino2008 ER - TY - JOUR AU - Zhang, W. AU - Gordon, M. AU - Schultheis, A. M. PY - 2007 DA - 2007// TI - Fc R2A and Fc R3A Polymorphisms associated with clinical outcome of epidermal growth factor receptor–expressing metastatic colorectal cancer patients treated with single-agent cetuximab JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.8021 DO - 10.1200/JCO.2006.08.8021 ID - Zhang2007 ER - TY - JOUR AU - Bibeau, F. AU - Lopez-Crapez, E. AU - Di Fiore, F. PY - 2009 DA - 2009// TI - Impact of Fc RIIa-Fc RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.0463 DO - 10.1200/JCO.2008.18.0463 ID - Bibeau2009 ER - TY - JOUR AU - Carotenuto, P. AU - Roma, C. AU - Cozzolino, S. PY - 2012 DA - 2012// TI - Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR JO - Int J Oncol VL - 40 ID - Carotenuto2012 ER - TY - JOUR AU - Jiang, X. M. AU - Arepally, G. AU - Poncz, M. AU - McKenzie, S. PY - 1996 DA - 1996// TI - Rapid detection of the FcyRIIA-H/R131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED) JO - J Immunol Methods VL - 199 UR - https://doi.org/10.1016/S0022-1759(96)00164-0 DO - 10.1016/S0022-1759(96)00164-0 ID - Jiang1996 ER - TY - JOUR AU - de Straat FG, L. -. v. AU - van der Pol, W. L. AU - Jansen, M. D. PY - 2000 DA - 2000// TI - A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping JO - J Immunol Methods VL - 242 UR - https://doi.org/10.1016/S0022-1759(00)00240-4 DO - 10.1016/S0022-1759(00)00240-4 ID - de Straat FG2000 ER - TY - JOUR AU - Overdijk, M. B. AU - Verploegen, S. AU - van den Brakel, J. H. PY - 2011 DA - 2011// TI - Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition JO - J Immunol VL - 187 UR - https://doi.org/10.4049/jimmunol.1003926 DO - 10.4049/jimmunol.1003926 ID - Overdijk2011 ER - TY - JOUR AU - Van Cutsem, E. AU - Tejpar, S. AU - Vanbeckevoort, D. PY - 2012 DA - 2012// TI - Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.40.9243 DO - 10.1200/JCO.2011.40.9243 ID - Van Cutsem2012 ER -